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The thermodynamic relationship between FI and FII of ethyl 4-aminobenzoate (benzocaine) has been
investigated. Slurry conversion experiments show that the transition temperature below which FI is
stable is located between 302 Ke303 K (29 Ce30 C). The polymorphs FI and FII have been characterised
by infrared spectroscopy (IR), Raman spectroscopy, transmission powder X-ray diffraction (XRPD) and
differential scanning calorimetry (DSC). The isobaric solid state heat capacities have been measured by
DSC. The quantitative thermodynamic stability relationship has been determined in a comprehensive
thermodynamic analysis of the calorimetric data. The solubility of both polymorphs has been determined
in eight pure organic solvents over the temperature range 278 Ke323 K by a gravimetric method. The
mole fraction solubility of benzocaine decreases in the order: 1,4-dioxane, acetone, ethyl acetate, chlo-
roform, acetonitrile, methanol, n-butanol and toluene. Comparison with the determined activity of solid
benzocaine forms shows that negative deviation from Raoult's law ideality is found in dioxane, acetone
and ethyl acetate solutions, and positive deviation in solutions of the other investigated solvents.
© 2020 The Authors. Published by Elsevier Inc. on behalf of the American Pharmacists Association®. This
is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).Introduction
Benzocaine is a para-substituted amino benzoate ester, Fig. 1.
It is a local anaesthetic, often used topically, and is commonly
available over-the-counter in single and compound dosage
forms for various mouth and skin discomforts. It is also used for
anaesthetising the oropharynx for procedures such as bron-
choscopy and trans-esophageal echocardiography.1 Although
generally well tolerated, it has been known to cause
methemoglobinemia.2
Three polymorphs of benzocaine (FI, FII and FIII) are known, all
of which have structures reported in the Cambridge Structural
database (CSD). The crystal structure of FII was first solved by Sinha
and Pattabhi3 in the orthorhombic space group P212121 (CSD
refcode QQQAXG01). The structure of FI was determined by Lynch
and McClenaghan4 in the monoclinic space group P21/c (CSD
refcode QQQAXG02). The solved single crystals (both FI and FII)
were grown from ethanol solution and exhibit great similarities in
the molecular stacking. The benzocaine molecules in bothInc. on behalf of the American Phastructures form chains with adjacent molecules connected by
NeH/O hydrogen bonds. Two chains form a ribbon, with the
methyl groups facing inwards towards the centre and the amine
groups on the outside. The main difference between FI and FII is
that the ribbon chains are anti-parallel and related by inversion
centres in FI, and parallel and related by a screw axis in FII.5 The
chain and ribbon motifs are shown in Fig. 2.
A low-temperature structural phase transition into the mono-
clinic (P21) FIII (CSD refcode: QQQAXG03) has been reported for FII5
and the pressureetemperature phase diagram involving FII and FIII
has been solved.6 No similar phase transitionwas observed to occur
for FI, which has been attributed to the differences in crystal
symmetry.
There are some studies reporting the solubility of benzocaine in
a small number of organic solvents and aqueous solutions.7e10
However, in most of these studies no polymorphic information is
provided to support the data. In the present work the solubility of
two benzocaine polymorphs (FI and FII) in eight pure organic sol-
vents at different temperatures has been determined using a
gravimetric method. In slurry conversion experiments, it is shown
that there is an enantiotropic relationship between FI and FII, and
that the commercially available FII is a metastable polymorph of
benzocaine at ambient conditions. Based on differential scanningrmacists Association®. This is an open access article under the CC BY license (http://
Fig. 1. Molecular structure of benzocaine.
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two polymorphs has been quantified.
Experimental Work
Materials
Ethyl 4-aminobenzoate (CAS reg. no. 94-09-7, purity 99.9% (GC),
verified to be FII by transmission XRPD) was purchased from Alfa
Aesar and used without further purification. FI used in this work
was obtained by slurrying excess FII in methanol at 10 C for one
day and drying under vacuum at room temperature. Organic sol-
vents were purchased from Sigma-Aldrich and used as received:
acetone (Chromasolv, 99.8%), acetonitrile (Chromasolv plus,
99.9%), n-butanol (Chromasolv plus, 99.7%), chloroform (Chro-
masolv, 99.8%), 1,4-dioxane (Chromasolv plus, 99.5%), ethyl ac-
etate (Chromasolv plus, 99.9%), methanol (Chromasolv, 99.9%)
and toluene (Chromasolv, 99.9%).
Experimental Setup
The setup consisted of a thermostatic water bath (Grant S26
stainless steel water bath; 26 L, 505  300  200 mm; equippedFig. 2. (a) Hydrogen bond chain motif, (b) ribbonwith a Grant C2G cooling unit and a Grant GR150 control unit; @
310 K, stability ±0.005 K and uniformity ±0.02 K) with a serial
submersible 60 points magnetic stirrer plate (2Mag) placed on the
base and a submersible water pump (1400 L/h) to enhance circu-
lation in the bath. The set temperature was validated by a digital
thermometer (D750 PT, Dostmann electronic, Wertheim, Germany,
uncertainty of ±0.01 K).Solubility of FI and FII
The solubility of benzocaine was determined in pure organic
solvents using a gravimetric method described previously.11 Solu-
tions with excess pure FI or FII were prepared in 30 mL glass vials,
each containing a PTFE-coated magnetic stirrer and sealed with a
screw cap with a PTFE coated insert. The vials were placed on a
magnetic stirrer plate submersed in a water bath under agitation at
600 rpm, for at least 18 h at each temperature to allow equilibrium
to be reached. Equilibrium was always approached from under-
saturated conditions, via dissolution. After equilibration, stirring
was turned off and excess solids allowed to settle for 1 h. Clear
solution was sampled using syringes (5 mL) and filtered through
syringe filters (PTFE, 25 mm, pore size 0.2 mm, VWR) into pre-
weighed glass vials. Syringes and filters were pre-heated to 5 K
above the saturation temperature to prevent nucleation inside the
syringes during sampling. The weight of each sample solution was
recorded immediately. The samples were dried in a ventilated fume
hood at room temperature and when the vials were visibly solvent-
free they were placed in an oven at 313 K for 6 h to ensure complete
dryness. All weights were determined with an Ohaus Explorer
balance (accuracy ±0.0001 g). At each temperature, the solids in
equilibrium with the solution were sampled by filtration and
quickly analysed by transmission XRPD in order to ensure that no
transformation of the original solid structure had occurred.motif in FI structure, (c) ribbon motif in FII.
Fig. 3. Experimental transmission XRPD patterns of FI (red, top panel) and FII (blue,
top panel); and of crystals following slurry conversion in n-butanol starting with a 1:1
mixture of FI and FII, at 302.15 K (middle panel) after 2 days and 4 days, and at 303.15 K
(bottom panel) after 18 h, 1 week and 3 weeks, respectively.
Fig. 4. IR transmission spectra of benzocaine FI (red) and FII (blue). Key regions of
differences are highlighted.
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Mechanical 1:1 mixtures of solid FI and FII in excess of solubility
were suspended in various pure solvents in 30 mL vials, agitated at
600 rpm and kept isothermally at different temperatures between
293.15 K and 313.15 K. Samples of solids were collected at different
time intervals and analysed with transmission XRPD within 20 min
to identify the polymorphic composition.
Solid-State Characterization
Solid samples of benzocaine have been identified and charac-
terized using attenuated total reflection infrared spectroscopy
(ATR-FTIR, PerkinElmer Spectrum 100 FT-IR spectrometer with a
Universal ATR sampling accessory), Raman spectroscopy (Kaiser
Raman Rxn2 analyzer), and transmission powder X-ray diffraction
(XRPD, PANalytical Empyrean).
Differential Scanning Calorimetry
Temperatures and associated enthalpies of phase trans-
formations (solid-to-solid andmelting) have been determinedwith
DSC using a TA Instruments Q2000 calorimeter. Powder samples
were encapsulated in Tzero aluminum pans and heated at a con-
stant rate of 5 Kmin1. The furnacewas purged with nitrogen gas at
50 mL min1. Calibration was carried out according to standard
procedure against the melting properties of indium. Heat capacities
of solid and supercooled melt samples have been determined by
temperature-modulated DSC, using a TA Instruments Q2000 calo-
rimeter. A modulation period of 100 s and an amplitude of 1 K were
used, with a constant underlying heating rate of 5 K min1. Powder
samples were encapsulated in Tzero aluminum pans, and following
an initial heating ramp past the melting point, were rapidly cooled
to 343 K (a temperature determined in preliminary experiments to
be slightly above the recrystallization point). The heat capacity of
the supercooled melt was obtained in a second heating step. The
furnace was purged with nitrogen gas at 50 mL min1, and the heat
capacity calibrated against sapphire using a linear temperature
correction function. Further exploratory temperature cycling was
carried out using a PerkinElmer Pyris 1 instrument, using a ramp
rate of 10 K min1.
Results and Discussion
X-ray Powder Diffraction
Transmission XRPD patterns of benzocaine polymorphs are
shown in Fig. 3 (top panel). The patterns are sufficiently distinct to
allow polymorph identification based on XRPD.
Spectroscopic Characterization
Mid-infrared spectra of solid FI and FII are very similar, see Fig. 4.
The unique regions of these two forms arewithin 2890e3000 cm1
and 3410e3460 cm1. The distinct peaks for FI are at 2897, 2937,
2953, 2979, 2995 and 3423 cm1 and the distinct peaks for FII are at
1745, 2900, 2985, 3420 and 3455 cm1. The high similarity in IR
spectra is expected considering the small difference in terms of
hydrogen bonding between the two forms.
Like for IR, the Raman spectrum of FI is very similar to that of FII
due to the strong similarities in the intermolecular packing of the
two forms. Only slight differences can be spotted within
1110e1470 cm1 and 2890e3060 cm1 regions. The distinct peaks
for FI are at 1113, 1367, 1395, 1458, 2897, 2939, 2963 and 2955
(double), 2995 and 2983 (double) and 3055 cm1 and the distinctpeaks for FII are at 1112, 1369, 1393, 1461, 2901, 2944, 2966 and
2959 (double), 2986 (shoulder) and 3057 cm1. The Raman spectra
are provided as supporting information.Thermal Analysis
DSC thermograms obtained on heating FI and FII are shown in
Fig. 5. FI is observed to transforms into FII with aweak endothermal
signal at an onset of 345.1 K. FII is then observed tomelt at 362.75 K
in both thermograms. The determined enthalpies and extrapolated
Table 1
DSC Data of Benzocaine Phase Transformations, Together with Standard Errors Over
5 Scans.
FI to FII Transformation Melting of FII
T (onset)/K 345.1 ± 0.76 362.75 ± 0.006
DH/kJ$mol1 0.25 ± 0.041 23.05 ± 0.042
D. Cheuk et al. / Journal of Pharmaceutical Sciences 109 (2020) 3370-3377 3373onset temperatures of these thermal events, averaged over 5 scans,
are given in Table 1 together with standard errors. The melting
point and the associated enthalpy of fusion of FII match well with
the values reported by Gana et al.6 (362.4 ± 0.5 K/
23.3 ± 0.4 kJ mol1) and are slightly higher than the values reported
by Schmidt12 (361.8 K/20.5 kJ mol1).
Samples of FI were subjected to two consecutive cooling-
heating cycles with a ramp rate of 10 K min1 (Thermograms are
provided as supporting information). The cycles were repeated
several times in order to isolate and identify the polymorphic form
at different transformation stages using XRPD. On cooling of FI from
room temperature to 243 K, no transformation was detected. On
heating, as mentioned above, FI transforms into FII at 345 K with a
weak endotherm, which then proceeds to melt at 363 K. On cooling
of the melt, FII recrystallizes at 340 K. On further cooling, FII
transforms into FIII at 262.9 K visible as a faint exothermal event.
This transformation is reversible on heating, occurring at 267.5 K
with a faint endothermal signal. No thermally induced trans-
formation from FII into FI was observed on either heating or
cooling.
Heat capacities of FI, FII and the supercooled melt are shown in
Fig. 6, determined over the temperature ranges 278 Ke310 K,
278 Ke350 K and 361 Ke378 K, as averages over 3, 4 and 5 scanned
samples, respectively. As can be seen, the heat capacities for both
solids and the melt are well described by linear functions of T
within the experimental temperature ranges (R2 > 99 for the solids
and >0.96 for the melt). Moreover, although there is a small, visibly
systematic difference in the mean value curves of the two forms,
there is no statistically significant difference between the heat ca-
pacities of FI and FII. For purposes of correlation, therefore, FI and
FII are treated as one dataset. A linear equation of two parameters,
Equation (1), is fitted to the heat capacities of the solid and themelt,
respectively. For the solid, the resulting values of the coefficients
are k1 ¼ 0.8445 J K2 mol1 and k2 ¼ 13.86 J K1 mol1 and for
the melt the values are k1 ¼ 0.3166 J K2 mol1 and
k2 ¼ 218.02 J K1 mol1. Experimental heat capacity data is given in
the supporting information.
Cp¼ k1T þ k2 (1)Fig. 5. DSC thermograms (5 K/min) starting with FI (a) and FII (b).Solubility in Organic Solvents
Table 2 presents mean values and standard deviations of
triplicate measurements of the solubility of FI and FII in
eight pure solvents at temperatures between 5 C and 50 C
(278.15 Ke323.15 K). The data is represented graphically in Fig. 7 on
mass basis with linear axis scales, and on mole fraction basis as a
van't Hoff plot in the supporting information. In all cases, XRPD
analysis of the excess solids isolated from the solubility experi-
ments confirmed that no polymorph transformation had occurred
during the equilibration process.
The mole fraction solubility data in each solvent was correlated
by Equation (2):
ln xeq ¼AT2 þ BT1 þ C: (2)
where T is in units of K and A, B and C are regression coefficients
valid within the temperature range 278.15 Ke303.15 K for benzo-
caine FI and 298.15 Ke323.15 K for benzocaine FII. The coefficients
of Equation (2) obtained for each solvent by least squares fitting to
the mole fraction solubility data are displayed in Table 3 together
with coefficients of determination. R2 values for all systems exceed
0.9987.Polymorphic Thermodynamic Stability Relationship
In DSC scans, FI is observed to convert to FII at 345 K on heating,
showing that at least above 345 K FII is the thermodynamically
stable polymorph. During solubility measurements, solvent-
mediated transformation from FI to FII within 18 h was detected
at temperatures of 308 K and above, while the reverse was
observed at 293 K and below. This clearly shows that, contrary to
some statements in the literature,6,12 the two polymorphs enjoy an
enantiotropic relationship, with FI being the stable phase at low
temperatures and FII the stable phase at high temperatures. XRPD
analyses of the crystals following slurry conversion experiments
throughout the range of organic solvents starting with a 1:1
mixture of FI and FII consistently show that at 302.15 K and below
the mixture gradually converts into FI, while at 303.15 K and above
the mixture transforms into FII. Fig. 3 shows the resulting XRPDFig. 6. Heat capacities of the solids (FI, red, and FII, blue) and the melt (L, green).
Table 2
Solubility of Benzocaine (FI and FII) in Eight Organic Solvents From 5 C to 50 C.
Solubility of Benzocaine (Standard Deviation Over Three Samples) (g/100 g solvent)
T/C Acetone Acetonitrile n-Butanol
FI FII FI FII FI FII
5 70.6974 (0.2658) / 34.9894 (0.6085) / 6.5998 (0.0181) /
10 80.3369 (0.5281) / 43.3613 (0.2828) / 8.1749 (0.0070) /
15 90.4405 (0.6600) / 54.2551 (0.8253) / 10.2383 (0.0854) /
20 102.8886 (0.1365) / 67.7594 (0.1702) / 12.9304 (0.0701) /
25 117.5526 (0.2046) 118.2688 (0.2919) 85.2906 (0.1178) 85.9946 (0.0805) 16.6179 (0.0329) 16.7977 (0.0463)
30 135.6283 (0.0692) 136.9235 (0.9487) 107.2157 (0.1875) 108.6056 (0.0527) 21.8921 (0.0457) 22.0412 (0.1045)
35 / 154.5039 (0.2814) / 133.2578 (0.7561) / 28.9386 (0.1833)
40 / 181.4534 (0.4430) / 168.9366 (0.4428) / 39.5156 (0.1350)
45 / 219.4896 (0.6436) / 209.7084 (0.5412) / 55.2306 (0.0236)
50 / 266.7387 (0.5118) / 267.2685 (0.4020) / 78.9409 (0.3362)
T/C Chloroform 1,4-Dioxane Ethyl Acetate
FI FII FI FII FI FII
5 15.9425 (0.0218) / / / 31.5769 (0.0325) /
10 19.4564 (0.1444) / 54.8997 (0.0313) / 36.3764 (0.0402) /
15 23.7517 (0.3343) / 62.6278 (0.4217) / 42.5126 (0.4542) /
20 28.5425 (0.0647) / 71.3266 (0.0551) / 48.7473 (0.0531) /
25 34.7568 (0.0212) 34.9724 (0.0436) 81.8273 (0.0747) 81.8037 (0.2518) 56.9717 (0.0323) 57.3010 (0.0213)
30 42.5979 (0.0752) 42.9346 (0.1197) 94.7907 (0.1798) 94.8222 (0.0726) 67.2142 (0.0264) 68.1018 (0.3871)
35 / 51.5993 (0.4518) / 108.3683 (0.3656) 78.8781 (0.2183)
40 / 62.9201 (0.3975) / 126.8882 (0.1547) 94.2945 (0.1804)
45 / 78.4406 (0.1661) / 146.9723 (0.5039) 111.9827 (0.1658)
50 / 96.4925 (0.5057) / 174.4565 (0.2678) 137.3240 (0.7147)
T/C Methanol Toluene
FI FII FI FII
5 20.7470 (0.0699) / 2.8877 (0.0066) /
10 25.5470 (0.1638) / 3.7631 (0.1296) /
15 31.6946 (0.3617) / 4.9107 (0.1617) /
20 40.6294 (0.0370) / 6.1428 (0.0198) /
25 52.8398 (0.5052) 52.0325 (0.2175) 8.2115 (0.0408) 8.3131 (0.0296)
30 69.1940 (0.2136) 69.0492 (0.2108) 11.3094 (0.0307) 11.2633 (0.1869)
35 / 91.6743 (0.2416) / 15.5703 (0.1605)
40 / 125.0009 (0.3845) / 23.4066 (0.0209)
45 / 170.8670 (0.8866) / 34.8521 (0.0111)
50 / 234.3026 (0.5183) / 54.0446 (0.2985)
D. Cheuk et al. / Journal of Pharmaceutical Sciences 109 (2020) 3370-33773374patterns obtained in n-butanol after different times. This conclu-
sively shows that the transformation temperature is located be-
tween 302.15 K and 303.15 K. This agrees with the published value
of Ttr estimated from solubility data in ethanol.7 Moreover, it isFig. 7. Solubility of benzocaine FI (top filled symbols) and FII (bottom filled symbols) in:, a
, methanol and , toluene.shown that FII also enjoys an enantiotropic relationship with FIII, as
given by the reversible low temperature transformation detected
with DSC. The transition temperature for this enantiotropic pair is
located in the interval 262.9 Ke267.5 K.cetone;, acetonitrile;, n-butanol;, chloroform;, 1,4-dioxane;, ethyl acetate;
Table 3
Coefficients of Equation (2) for Benzocaine FI (Valid Between 278.15 K and 303.15 K) and FII (Valid Between 298.15 K and 323.15 K), Together with Coefficients of Determination.
FI (278.15 Ke303.15 K) FII (298.15 Ke323.15 K)
105 A/K2 103 B/K C R2 105 A/K2 103 B/K C R2
Acetone 5.1250 5.1537 10.2920 0.9999 15.6690 12.0160 21.4537 0.9991
Acetonitrile 5.5126 7.0708 15.7684 1.0000 4.8454 0.0137 3.7624 0.9997
Butanol 26.6876 22.2068 41.7965 0.9999 32.7800 26.2213 48.4135 0.9999
Chloroform 0.9667 3.4305 8.8154 0.9999 0.1231 2.6566 7.4503 0.9997
1,4-Dioxane 5.1180 5.1797 10.4252 0.9999 2.3171 3.2623 7.1453 0.9997
Ethyl acetate 5.4856 5.8123 11.8696 0.9997 6.0162 6.1335 12.3554 0.9995
Methanol 29.2199 23.9223 44.9853 0.9999 5.7732 8.4715 19.5274 0.9999
Toluene 27.0080 22.9918 43.6173 0.9987 52.9199 40.5377 73.3119 0.9997
Fig. 8. Gibbs energy, enthalpy and entropy of fusion of FI (red) and FII (blue).
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benzocaine polymorphs as well as the kinetic stability against
transformation in the solid state has important implications for
pharmaceutical formulation processes as well as for the storage
conditions of solid formulations. It is noteworthy that benzocaine
has an enantiotropic transition temperature close to room tem-
perature, and has been shown to convert readily to the high-
temperature stable form in the dry state on heating.
With a combined analysis of calorimetric data and the slurry
conversion experiments it is possible to estimate the quantitative
thermodynamic stability relationship between the two poly-
morphs FI and FII, as well as the melting temperature of FI. The
transition temperature is taken as the midpoint between the two
boundary values obtained by XRPD, viz. 302.65 K. The enthalpy of
transformation from FI to FII as obtained by DSC is 0.25 kJ mol1 at
345.1 K. If the heat capacities of FI and FII can be assumed to be
equal over the entire temperature range, it follows that the
enthalpy difference between the two polymorphs will likewise be
constant. Hence, at Ttr ¼ 302.65 K, DtrG ≡ 0, DtrH and
TDtrS ¼ 0.25 kJ mol1 and DtrS ¼ 0.73 J K1 mol1. Together, the low
value of the enthalpy of transformation and the similarity in heat
capacities indicate that the two polymorphs are very similar in
thermodynamic terms, as can indeed be observed from the close-
ness of the solubility curves. This also mirrors the similarity in
crystal structure, Fig. 2.
By choosing the supercooled melt as a reference state, the Gibbs
energy, enthalpy and entropy of fusion can be estimated as func-
tions of temperature from calorimetric data, as previously
expounded:13














Where DCp ¼ Cp,L e Cp,S. Using the melting data of the high-
temperature stable FII in Table 1 together with the heat capacity
as modelled with Equation (1), the thermodynamic functions of
fusion of FII have been estimated. The corresponding data for fusion
of FI has been estimated by combination with the data for trans-
formation. Fig. 8 shows the thermodynamic stability relationship
between the polymorphs as functions of temperature, with the
supercooled melt as common reference state.
As can be seen in Fig. 8, the thermodynamic properties of the
two polymorphs are very similar over the entire temperatureinterval. The estimated (absolute) difference in Gibbs energy is
19.5 J/mol at 278 K, the lower temperature limit of experimental
solubility data, and 17.9 J/mol at 323 K, the upper limit. With
reference to the supercooled melt, these differences amount to just
0.4% and 0.8% of the total Gibbs energy of fusion, respectively. By
extrapolation of the curve DfusGFI (T) to zero, the melting point of FI
is estimated to 362.0 K e a difference of only 0.8 K compared with
FII. The uncertainty in the estimated values for FI and FII derive
from uncertainties in Ttr, in the experimental calorimetric data, and
in the assumption that heat capacities are linear with temperature
over the entire temperature range from 278 K to the melting point.
If the reference state is taken as the pure supercooled solute
melt, the activity of the pure solid can be obtained as a function of
temperature from the Gibbs energy of fusion:




The activity of the solid is also known as the ideal solubility, as it
is equal to the solubility in an ideal solution where the activity
coefficient, g, is unity:
ln xeq ¼ ln as  ln geq (7)
In Fig. 9a, the solubility of benzocaine in the eight evaluated
organic solvents is plotted over the experimental temperature in-
terval, 278 Ke323 K, as the natural logarithm of the mole fraction
against the reciprocal of the absolute temperature, in a graph that
also shows the ideal solubility. In Fig. 9b, the activity coefficient of
benzocaine in saturated solutions of the eight organic solvents is
plotted vs. temperature over the experimental interval. Solubilities
are modelled using Equation (2) together with the coefficients in
Table 3 e for temperatures below Ttr, FI values are shown, and
above Ttr, FII values are shown. The activity coefficient is calculated
using Equation (7).
Fig. 9. (a) van't Hoff plot of solubility modelled using Equation (2) and coefficients in
Table 3, together with the activity of the solid phase (ideal solubility); (b) solute ac-
tivity coefficients at equilibrium, modelled using Equation (7), in 8 organic solvents.
D. Cheuk et al. / Journal of Pharmaceutical Sciences 109 (2020) 3370-33773376The graphs clearly show that the solubility exceeds that of an
ideal solution in three solvents; dioxane, acetone and ethyl acetate,
in which solvents the corresponding activity coefficients are below
unity (negative deviation from Raoult's law). In five solvents;
chloroform, acetonitrile, methanol, butanol and toluene, the solu-
bility is lower than the ideal value, and the corresponding activity
coefficients are above unity (positive deviation). The deviation is
significant for the alcohols and toluene, while in ethyl acetate and
chloroform the solubility is very close to ideal. The activity co-
efficients all visibly approach unity with increasing temperature.
Notably, the solubility curves in the van't Hoff plot as well as the
activity coefficient curves are all distinctly non-linear over the
investigated temperature interval. However, because of the prox-
imity to the melting point (low Gibbs energy of fusion, translating
into a high solid phase activity) the solubility of benzocaine is
overall high in all the solvents evaluated.
There is no obvious, straightforward correlation between the
solubility and the solvent polarity, as quantified either with the
dielectric constant or the Reichardt polarity parameter.14 The solu-
bility is lowest in the least polar solvent toluene, followed by the two
most polar solvents, the aliphatic alcohols, and noticeably higher in
the solvents of low tomediumpolarity. Thebenzocainemolecule has
both hydrogen-bond donor and acceptor functionality, and such
donor-acceptor interaction is an important feature of the crystal
structures of both polymorphs. Because of the high solid phase ac-
tivity the ideal solubility is high. This results inhigh concentrationsof
solute molecules in all the solutions evaluated, and potentially sig-
nificant solute-solute hydrogenbonding. The three solvents inwhich
the solubility is higher than the ideal value are all electron pair
donating and aprotic. The fourth highest solubility is measured in
acetonitrile which is also electron pair donating and aprotic, and the
fifth highest solubility is in the electron pair donating solvent chlo-
roform.Accordingly, a high solubility is observed in solvents inwhich
solvation is promoted by hydrogen bondingwith the hydrogen bonddonating functionality of the benzocaine amine group, competing
with the corresponding solute-solute hydrogen bonding interaction.
However, it is also to be noticed that in all these five solvents there is
no competing solvente solventhydrogenbonding, since theyall lack
the hydrogen bond donating functionality. Conversely, the alcohols
are able to hydrogen bondwith both the donating and the accepting
functionality of the benzocaine molecule, but these interactions
compete with corresponding solvent e solvent interaction, which
explains the lower solubility. Finally, the low solubility in toluene is
reasonable given the poor ability to solvate the polar parts of the
benzocainemolecule, and the lack of hydrogen bonding capability to
compete with the solute-solute hydrogen bonding.
Conclusions
Benzocaine FII melts at 362.75 K with an associated enthalpy of
fusion of 23.05 kJ mol. FI transforms into FII on heating, with a
detected enthalpy of transformation of 0.25 kJ mol at 345 K. The
isobaric specific heat capacities of the two polymorphs are similar,
increasing linearly with temperature, and the heat capacity of the
melt also expresses a linear increase with temperature, with a
weaker slope. Slurry conversion experiments in several organic
solvents show that the two polymorphs are enantiotropes, and that
the transition temperature belowwhich FI is stable is located in the
range 302.15 Ke303.15 K. The quantitative thermodynamic stability
relationship between the polymorphs has been determined in a
comprehensive analysis of the experimental data. Based on this
analysis, the melting point of FI is estimated to 362.0 K. The solu-
bility of benzocaine in eight pure organic solvents is overall high:
expressed on mass basis it is highest in acetone, ranging from 71 g/
100 g solvent at 5 C to 267 g/100 g solvent at 50 C, and lowest in
toluene, ranging from 3 g/100 g solvent at 5 C to 54 g/100 g solvent
at 50 C. The mole fraction solubility decreases in the order: 1,4-
dioxane, acetone, ethyl acetate, chloroform, acetonitrile, methanol,
n-butanol and toluene. Comparisonwith the determined activity of
solid benzocaine FI and FII shows that there is a negative deviation
fromRaoult's law in dioxane, acetone and ethyl acetate, and positive
deviation in chloroform, acetonitrile, methanol, butanol and
toluene. Solutions in ethyl acetate and chloroform are close to ideal.
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